AXT (AXTI) is a U.S. manufacturer of semiconductor substrates—wafers on which electronic and optical components are built. Indium phosphide substrates are used in lasers and photodetectors for high-speed data transmission in AI data centers. Freedom analysts recommend the stock as a “Buy”: product shortages and capacity expansion could support a rebound in the share price after the pullback.
Investment idea drivers:
- Results and guidance beat expectations. In Q3, AXT’s revenue rose 162% year over year to a record $73.4 million. Adjusted EPS reached $0.41 versus the expected $0.31. For Q4, the company forecasts revenue of about $90 million and EPS of $0.57–0.59. The outlook includes only shipments for which export licenses have already been obtained or are not required.
- Demand exceeds production capacity. The order backlog topped $500 million versus more than $100 million the prior quarter, and lead times for some items exceed nine months. Indium phosphide substrates accounted for 74% of quarterly revenue. Additional confirmation of demand was a $43.5 million prepayment from Lumentum under a long-term contract.
- Capacity is ramping faster than planned. The company’s goal to double indium phosphide substrate output in 2026 was achieved as early as August. By year-end, capacity is expected to increase 2.75–3x versus end-2025, and in 2027 AXT plans to double it again. Analysts believe market forecasts do not yet fully reflect the potential of such an expansion.
- Higher output supports profitability. Adjusted gross margin increased to 56.1% versus 22.4% a year earlier. It is supported by price increases, productivity gains, and customers shifting to larger-diameter wafers. Management estimates the metric could exceed 60% in Q4.
Target price: $85